Zolpidem Tartrate Tablet, Film Coated, Extended Release
Product Images NDC 47335-308

4 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 47335-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of Zolpidem Tartrate, showing the molecular arrangement of the Zolpidem moiety combined with tartaric acid components, represented as a dimer complex.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph showing mean plasma concentration-time profiles comparing Zolpidem Tartrate extended-release tablets (12.5 mg) and immediate-release tablets (10 mg). The x-axis represents time in hours (0 to 8), and the y-axis shows zolpidem plasma concentrations in ng/mL (0 to 120). Two curves illustrate the concentration changes over time for each tablet formulation.*
FDA Label Image

625mglabel (Spl Zolpidem Label 1)

FDA Label Image

125mglabel (Spl Zolpidem Label 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.